School of Medicine, Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA, 30310, USA.
Department of Radiology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA, 94305, USA.
Abdom Radiol (NY). 2024 Jan;49(1):202-208. doi: 10.1007/s00261-023-04091-w. Epub 2023 Nov 16.
To assess discrepancies in current imaging recommendations for hematuria among North American societies: American College of Radiology (ACR), American Urological Association (AUA), and Canadian Urological Association (CUA).
The latest available ACR Appropriateness Recommendations, AUA guidelines, and CUA guidelines were reviewed. AUA and CUA guidelines imaging recommendations by variants and level of appropriateness were converted to match the style of ACR. Imaging recommendations including modality, anatomy, and requirement for contrast were recorded.
Clinical variants included microhematuria without risk factors, microhematuria with risk factors, gross hematuria, and microhematuria during pregnancy. CUA recommends ultrasound kidneys as the first-line imaging study in the first 3 variants; pregnancy is not explicitly addressed. For hematuria without risk factors, ACR does not routinely recommend imaging, while AUA recommends shared decision-making to decide repeat urinalysis versus cystoscopy with ultrasound kidneys. For hematuria with risk factors and gross hematuria, ACR recommends CT urography; MR urography can also be considered in gross hematuria. AUA further stratifies intermediate- and high-risk patients, for which ultrasound kidneys and CT urography are recommended, respectively. For pregnancy, ACR and AUA both recommend ultrasound kidneys, though AUA additionally recommends consideration of CT or MR urography after delivery.
There is no universally agreed upon algorithm for diagnostic evaluation. Discrepancies centered on the role of upper tract imaging with ultrasound versus CT. Prospective studies and/or repeat simulation studies that apply newly updated guidelines are needed to further clarify the role of imaging, particularly for patients with microhematuria with no and intermediate risk factors.
评估北美学会(美国放射学院 [ACR]、美国泌尿外科学会 [AUA] 和加拿大泌尿外科学会 [CUA])当前血尿影像学建议中的差异。
回顾了最新的 ACR 适宜性推荐、AUA 指南和 CUA 指南。将 AUA 和 CUA 指南的影像学建议按变体和适宜性级别转换为与 ACR 风格匹配的格式。记录影像学建议包括的方式、解剖结构和对造影剂的要求。
临床变体包括无危险因素的镜下血尿、有危险因素的镜下血尿、肉眼血尿和妊娠期间的镜下血尿。CUA 建议在头 3 种变体中首先进行超声肾脏检查;妊娠未明确提及。对于无危险因素的血尿,ACR 不常规推荐进行影像学检查,而 AUA 建议共同决策,决定重复尿液分析还是进行超声肾脏检查联合膀胱镜检查。对于有危险因素和肉眼血尿的血尿,ACR 推荐 CT 尿路造影;磁共振尿路造影也可用于肉眼血尿。AUA 进一步将中危和高危患者分层,分别推荐超声肾脏和 CT 尿路造影。对于妊娠,ACR 和 AUA 均推荐超声肾脏,但 AUA 还建议在分娩后考虑 CT 或磁共振尿路造影。
目前尚无普遍认可的诊断评估算法。差异主要集中在上尿路超声与 CT 检查的作用上。需要前瞻性研究和/或重复应用最新指南的模拟研究来进一步阐明影像学的作用,特别是对于无和中危因素的镜下血尿患者。